B-Secur

About

B-Secur is a biosensing algorithm company based in Belfast, Northern Ireland, focused on heart health technology. Founded in 2014, it has evolved from a startup into a recognized leader in the medical device and health analytics sectors, raising $23.64 million in funding. The company specializes in harnessing the electrical signals of the heartbeat (ECG) for personal authentication and physiological monitoring. B-Secur's main product, HeartKey, features ECG algorithms that enhance signal clarity and provide FDA-cleared health data. HeartKey offers two key capabilities: biometric identification for data protection and medical-grade monitoring of heart rate, stress, and fatigue. This technology is applicable in various devices, including watches and rings, and is integrated into products from major partners like Medtronic, Abbott, and GE Healthcare. B-Secur's commitment to intellectual property has established it as a global leader in biosensing technology.